Depressive symptoms mediate COVID-associated stigma and quality of life: Stigma instrument validation and path analysis.

ABSTRACT:

Background

The aim of this study was to adapt and modify the HIV/AIDS Stigma Instrument-Patient to develop the COVID-19 Stigma Instrument-Patient (CSI-P) and validate its psychometric characteristics, as well as explore how affected individuals in China experienced COVID-related stigma and its associated variables, including depressive symptomology and quality of life (QOL).

Methods

From September to October 2020, 151 COVID-19 survivors recruited in Shanghai, China, completed a set of measures of demographic characteristics, depression, stigma, and QOL.

Results

The 15-item CSI-P-2 achieved a Cronbach's α of 0.67 to 0.91. The six-factor structure was obtained by exploratory factor analysis. The mean score for the CSI-P-2 in Chinese COVID survivors was 8.14 ± 9.98. Regr

SUBMITTER: Huang F 

PROVIDER: S-EPMC8541885 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature